Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II

Implantable ventricular assist devices are an effective treatment option for end-stage heart failure patients as a bridge to cardiac transplantation, to improve the clinical condition and organ function allowing discharge from the hospital to await for transplantation. The second alternative is to u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bunster,Nicolás, Villavicencio,Mauricio, Lim,Jongsung, Donoso,Erika, Gajardo,Francesca, Rossel,Víctor
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2014
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000400016
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872014000400016
record_format dspace
spelling oai:scielo:S0034-988720140004000162014-09-02Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate IIBunster,NicolásVillavicencio,MauricioLim,JongsungDonoso,ErikaGajardo,FrancescaRossel,Víctor Chile Heart assist devices Heart transplantation Implantable ventricular assist devices are an effective treatment option for end-stage heart failure patients as a bridge to cardiac transplantation, to improve the clinical condition and organ function allowing discharge from the hospital to await for transplantation. The second alternative is to use the device as destination therapy for patients with contraindications for cardiac transplantation, in whom it is maintained indefinitely. We report a 43-year-old patient, with a dilated cardiomyopathy, severe left ventricular dysfunction and advanced heart failure. A ventricular assist device Heart Mate II©, as a bridge to transplantation, was implanted to the patient in the United States. It was explanted for the first time in Chile at the National Thorax Institute. Heart transplantation was performed using the bicaval technique. Induction of immunosuppression was done with basiliximab. Generic immunosuppression was carried out with cyclosporine, mycophenolate mofetil and prednisone. Postoperatively the patient evolved with right femoral vein thrombosis in the femoral cannulation site, phlegmasia alba dolens, rhabdomyolysis, oliguric acute renal failure, which required renal replacement therapy, severe shock, with high requirements of vasoactive drugs and need for mechanical ventilation. He required a reoperation for hemothorax and had an Enterobacter pneumonia. After a period of serious illness, he began a gradual recovery and was discharged from the hospital after 58 days. After two years, he remains in functional class I, with a normal graft function.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.142 n.4 20142014-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000400016es10.4067/S0034-98872014000400016
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Chile
Heart assist devices
Heart transplantation
spellingShingle Chile
Heart assist devices
Heart transplantation
Bunster,Nicolás
Villavicencio,Mauricio
Lim,Jongsung
Donoso,Erika
Gajardo,Francesca
Rossel,Víctor
Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
description Implantable ventricular assist devices are an effective treatment option for end-stage heart failure patients as a bridge to cardiac transplantation, to improve the clinical condition and organ function allowing discharge from the hospital to await for transplantation. The second alternative is to use the device as destination therapy for patients with contraindications for cardiac transplantation, in whom it is maintained indefinitely. We report a 43-year-old patient, with a dilated cardiomyopathy, severe left ventricular dysfunction and advanced heart failure. A ventricular assist device Heart Mate II©, as a bridge to transplantation, was implanted to the patient in the United States. It was explanted for the first time in Chile at the National Thorax Institute. Heart transplantation was performed using the bicaval technique. Induction of immunosuppression was done with basiliximab. Generic immunosuppression was carried out with cyclosporine, mycophenolate mofetil and prednisone. Postoperatively the patient evolved with right femoral vein thrombosis in the femoral cannulation site, phlegmasia alba dolens, rhabdomyolysis, oliguric acute renal failure, which required renal replacement therapy, severe shock, with high requirements of vasoactive drugs and need for mechanical ventilation. He required a reoperation for hemothorax and had an Enterobacter pneumonia. After a period of serious illness, he began a gradual recovery and was discharged from the hospital after 58 days. After two years, he remains in functional class I, with a normal graft function.
author Bunster,Nicolás
Villavicencio,Mauricio
Lim,Jongsung
Donoso,Erika
Gajardo,Francesca
Rossel,Víctor
author_facet Bunster,Nicolás
Villavicencio,Mauricio
Lim,Jongsung
Donoso,Erika
Gajardo,Francesca
Rossel,Víctor
author_sort Bunster,Nicolás
title Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
title_short Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
title_full Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
title_fullStr Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
title_full_unstemmed Primer puente a trasplante cardiaco exitoso en Chile usando el dispositivo Heart Mate II
title_sort primer puente a trasplante cardiaco exitoso en chile usando el dispositivo heart mate ii
publisher Sociedad Médica de Santiago
publishDate 2014
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000400016
work_keys_str_mv AT bunsternicolas primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
AT villavicenciomauricio primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
AT limjongsung primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
AT donosoerika primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
AT gajardofrancesca primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
AT rosselvictor primerpuenteatrasplantecardiacoexitosoenchileusandoeldispositivoheartmateii
_version_ 1718436750660993024